TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 316 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2019. The put-call ratio across all filers is 1.05 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $9,810,840 | +263.5% | 628,900 | +324.0% | 0.06% | +850.0% |
| Q4 2020 | $2,699,000 | -1.5% | 148,324 | -3.4% | 0.01% | 0.0% |
| Q3 2020 | $2,740,000 | +0.2% | 153,580 | +0.7% | 0.01% | -33.3% |
| Q2 2020 | $2,735,000 | +226.8% | 152,540 | +176.4% | 0.01% | +80.0% |
| Q1 2020 | $837,000 | -55.2% | 55,185 | -41.7% | 0.01% | -44.4% |
| Q4 2019 | $1,868,000 | +12.6% | 94,686 | -1.8% | 0.01% | -18.2% |
| Q3 2019 | $1,659,000 | +48.4% | 96,452 | +52.7% | 0.01% | +57.1% |
| Q2 2019 | $1,118,000 | +299.3% | 63,165 | +358.8% | 0.01% | +250.0% |
| Q1 2019 | $280,000 | – | 13,767 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Adelphi Capital LLP | 8,958,784 | $176,757,000 | 33.75% |
| Ovata Capital Management Ltd | 879,800 | $17,557,092,000 | 13.04% |
| Paulson & Co. | 13,244,711 | $261,318,000 | 5.64% |
| Glenview Capital Management | 30,582,721 | $603,397,000 | 5.28% |
| MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC | 718,028 | $14,167,000 | 4.85% |
| Velanne Asset Management Ltd | 302,694 | $5,972,000 | 3.52% |
| Blackcrane Capital, LLC | 172,708 | $3,408,000 | 2.72% |
| Melqart Asset Management (UK) Ltd | 1,557,000 | $30,720,000 | 2.57% |
| GMT CAPITAL CORP | 3,345,976 | $66,016,000 | 2.55% |
| REDWOOD CAPITAL MANAGEMENT, LLC | 827,955 | $16,336,000 | 2.24% |